DERM
Journey Medical CorpNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$164.11M
P/E Ratio
—
EPS
$-0.37
Beta
1.03
52W High
$9.55
52W Low
$4.31
50-Day MA
$5.58
200-Day MA
$7.24
Dividend Yield
—
Profit Margin
-14.80%
Forward P/E
212.77
PEG Ratio
—
About Journey Medical Corp
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
Fundamentals
| Revenue (TTM) | $64.68M |
| Gross Profit (TTM) | $42.33M |
| EBITDA | $-2.02M |
| Operating Margin | -9.35% |
| Return on Equity | -36.60% |
| Return on Assets | -4.49% |
| Revenue/Share (TTM) | $2.52 |
| Book Value | $1.13 |
| Price-to-Book | 5.31 |
| Price-to-Sales (TTM) | 2.54 |
| EV/Revenue | 2.506 |
| EV/EBITDA | 17.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 21.50% |
| Shares Outstanding | $21.53M |
| Float | $14.83M |
| % Insiders | 32.31% |
| % Institutions | 55.68% |
Historical Volatility
HV 10-Day
108.04%
HV 20-Day
80.97%
HV 30-Day
70.74%
HV 60-Day
98.44%
HV Rank
76.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($13.50 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026